DZ Bank Aktienanleihe MRK 31.12.2.../ DE000DJ43L10 /
5/30/2024 12:34:34 PM | Chg.-0.470 | Bid1:13:32 PM | Ask1:13:32 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
98.570EUR | -0.47% | 98.580 Bid Size: 200,000 |
98.680 Ask Size: 200,000 |
MERCK KGAA O.N. | 160.00 EUR | 12/31/2024 | Call |
GlobeNewswire
1:00 PM
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
5/29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA